BTIG Believes Abbot (ABT) May be Renegotating Terms of Alere (ALR) Deal; Affirms at 'Buy'

Go back to BTIG Believes Abbot (ABT) May be Renegotating Terms of Alere (ALR) Deal; Affirms at 'Buy'

Alere (ALR) Said Near Loan Deal to Waive Default on 10-K Delay - Bloomberg

April 21, 2016 5:20 PM EDT

Alere (NYSE: ALR) Said Near Loan Deal to Waive Default on 10-K Delay - Bloomberg

... More

Abbott (ABT) Declined to Comment on Alere (ALR) Beyond CEO's Comment on Call - Bloomberg

April 20, 2016 10:14 AM EDT

Abbott (NYSE: ABT) Declined to Comment on Alere (NYSE: ALR) Beyond CEO's Comment on Call - Bloomberg

... More

Alere (ALR) Pressured on Market Open After Abbott (ABT) Declines to Comment on Deal

April 20, 2016 9:45 AM EDT

(Updated)

Alere (NYSE: ALR) shares were pressured on the market open Wednesday, falling 14%. Earlier Abbott (NYSE: ABT) management declined to comment on its previous agreement to acquire the company.

In March Alere received a grand jury subpoena... More

Abbott (ABT) Tops Q1 EPS by 2c; Boosts FY16 EPS Outlook

April 20, 2016 7:46 AM EDT

Abbott (NYSE: ABT) reported Q1 EPS of $0.41, $0.02 better than the analyst estimate of $0.39. Revenue for the quarter came in at $4.9 billion versus the consensus estimate of $4.78 billion.

GUIDANCE:

Abbott sees FY2016 EPS of $2.14 - $2.24, versus prior guidance of $2.10 - $2.20 and... More